S H Kelkar and Company Limited (SHK) Earnings Call Transcript & Summary
May 18, 2026
What were the key takeaways from S H Kelkar and Company Limited's May 18, 2026 earnings call?
In Q4 FY 2026, S H Kelkar and Company Limited reported steady revenue growth despite a challenging operating environment, with revenues reflecting a one-off sale of low-margin products. The company achieved an adjusted EBITDA of INR 283 crores, maintaining EBITDA margins at 13.5%. Management signaled cautious optimism for the first half of FY 2027, indicating that while raw material price pressures persist, they expect to maintain margins and secure growth through strategic pricing and customer engagement initiatives.
What topics did S H Kelkar and Company Limited cover?
- Revenue Growth Amid Challenges: S H Kelkar reported revenue growth supported by resilient demand across core categories, despite geopolitical and inflationary pressures. Management stated, "we delivered an encouraging revenue growth, supported by resilient demand across all our core categories and steady progress in the new markets."
- Operational Capacity Expansion: The company has successfully operationalized the Almere factory in the Netherlands, which is expected to enhance European growth capacity. Management noted, "The Almere factory at Netherlands greenfield facility is now fully operational, thus debottlenecking our European growth."
- Portfolio Optimization Efforts: Management highlighted a one-off sale of INR 35 crores of low-margin products as part of ongoing portfolio optimization. They emphasized the importance of exiting low-margin transactions to protect overall margins, stating, "we are continuously reviewing our product and customer portfolio and taking conscious decisions to exit transactions that are structurally low margin."
- Guidance for FY 2027: Management maintained a cautious outlook for FY 2027, indicating that while the first half looks stable, the second half remains uncertain due to raw material supply dynamics. They mentioned, "we are on track for a normal quarter 1... beyond the first half, it's very difficult to give a certain view of where the market is headed."
- Impact of Raw Material Prices: Management acknowledged the ongoing pressures from rising raw material prices and indicated that they are prepared to pass these costs onto customers. They stated, "we are in a position to pass on the raw material price increases."
What were S H Kelkar and Company Limited's May 18, 2026 results?
- Revenue: INR 2,100 crores (vs INR 2,050 crores est, +5% YoY)
- Adjusted EBITDA: INR 283 crores (vs INR 270 crores est, +3% YoY)
- EBITDA Margin: 13.5% (vs 13.2% est, inline)
- Profit After Tax: INR 150 crores (vs INR 160 crores est, -6% YoY)
- Gross Margin: 40% (vs 42% previous quarter, -2% QoQ)
- CapEx: INR 140 crores (for FY 2027, focused on operational expansion)
S H Kelkar's Q4 FY 2026 results reflect a resilient performance amid challenging conditions, with management signaling cautious optimism for the near term. The company's focus on operational expansion, strategic pricing, and long-term growth initiatives positions it well for future opportunities, though risks from raw material price volatility and geopolitical factors remain. Investors should monitor the execution of growth strategies and margin management closely.
Earnings Call Speaker Segments
Good day, everyone, and welcome to the S H Kelkar and Company Limited earnings conference call, brought to you by CDR India. <<operator_script>> Kindly be aware that this conference is being recorded. At this point, I'll turn the conference over to Mr. Anoop Poojari of CDR India for his opening remarks. Thank you, and the floor is yours, Anoop.
Thank you, and good morning to all of you for being with us on the Q4 and FY 2026 Earnings Conference Call of S H Kelkar and Company Limited. Joining us today are Mr. Kedar Vaze, Whole Time Director and Group CEO; Mr. B Ramakrishnan, CEO, Fragrances Asia and U.S.A.; and Mr. Jagdish Agarwal, Group CFO of the company. Management will start with opening remarks, and after that we will open the forum for a question-and-answer session. Before we begin, please note that certain statements on today's call could be forward-looking in nature, and a disclaimer covering this has been included in the earnings presentation that was shared with you earlier. I would now like to invite Kedar to deliver his opening remarks.
Good morning, everyone, and thanks for being with us on the S H Kelkar and Company earnings call covering the fourth quarter and financial year 2026. For the company, financial year 2026 brought steady progress as we kept building a stronger platform for the next stage of growth. Even with an operating environment that kept shifting, we posted encouraging revenue growth, helped by resilient demand throughout all our core categories and by steady advances in the new markets. One major area of emphasis this year involved developing capabilities that underpin longer-term growth. Creative development centers in key markets now take an active part in new product development, customer engagement and innovation tailored to specific markets. As these centers grow more integrated into our worldwide innovation and delivery framework, we are encouraged by how much engagement we see with new and existing customers. Given how product development, testing, approvals and adoption cycles work, customer conversion and scale-up in our industry usually takes time. That said, when relationships are built and products become embedded in customer portfolios, they tend to last a long duration. So although these centers will contribute progressively, we believe that over time they have the potential to meaningfully transform our business profile.
As these capabilities mature, they're going to boost our global relevance with customers, support growth that's higher quality and higher margin, and strengthen the company's position across key international markets. We're also making good progress on our expansion initiatives. The Almere factory, our greenfield facility in the Netherlands, is now fully operational, and that debottlenecks our European growth, which was approaching full capacity utilization. The Vanavate facility in Maharashtra is expected to go on stream in the coming months as well. These additions will give us greater operational capacity and support the ramp-up of business across the regions over the next few years. Together with the rebuilding of the Vashivali facility, these capacity additions are expected to address our requirements in the respective geographies for the foreseeable future. It will also strengthen our ability to respond to customer requirements more efficiently as we scale across domestic and international markets. These capacity additions, along with our investments in customer access, innovation, and market-specific capabilities, provide a stronger CapEx-ready foundation for growth over the coming years. The broader environment continues to be fluid, with evolving geopolitical developments and supply side dynamics globally. Our strong customer relationships, diversified presence, and improving operating platform position us well to navigate these uncertainties and capitalize on the emerging opportunities.
So with that said, I'll turn things over to Jagdish, who will take you through the financials and the key priorities. Jagdish, over to you.
Thank you, Kedar. Good morning, everyone, and thanks for being on this earnings call. As we all know, the worldwide situation is still difficult, with geopolitical and macroeconomic uncertainty affecting businesses in every sector. Even so, the quarterly and annual results we presented last Friday show performance that has stayed broadly consistent with the guidance we set. In many respects, those results demonstrate the preparatory steps we have been taking ahead of the current market conditions. You will have observed that in the quarter, we recorded a one-off sale of roughly INR 35 crores of low margin product, or negative margin product, as part of the portfolio optimization exercise we are continually pursuing. We keep reviewing our product and customer portfolio and are making deliberate choices to exit transactions that are structurally low margin and unsustainable, especially in today's inflationary environment shaped by the Middle East situation and wider geopolitical developments. Our main objective is unchanged, protecting margins while making sure our customers have supply security. The situation is still highly dynamic, particularly since raw material prices are rising frequently. In several instances, unless orders are booked or blocked right away, pricing can shift literally overnight, even by the next day. So we therefore keep working very closely with our customers to ensure continuity of supply and operational stability.
This strategy could cause some inventory to pile up for a while and push borrowing levels higher. Still, over the medium to long term, we remain squarely focused on generating cash, reinforcing the balance sheet, and bringing debt down. On the profitability side, adjusted EBITDA came in at INR 283 crores, with EBITDA margins near 13.5%, holding steady compared with the prior quarter. As I mentioned earlier, the operating environment stays dynamic, with raw material prices rising because of geopolitical developments in the Middle East and shifting supply-side conditions. Thanks to existing inventory coverage, the current quarter saw no meaningful impact from these pressures. That said, these higher costs could show up in the quarters ahead, and we are actively pursuing suitable pricing actions and cost optimization efforts to safeguard margins. Profit after tax for the year was affected by a higher effective tax rate at the consol level, reflecting the impact of losses in subsidiaries. With that, we can open the floor for questions or any feedback you may have.
<<operator_script>> Our first question comes from Ritesh Gandhi, who is on the line from Discover Capital.
Sir, we've completed roughly INR 350 crores of CapEx over the past few years. And even with all of that, at the EBITDA level, we simply aren't showing growth. I get that we've faced some industry headwinds. I get that there's some expansion that's currently producing operating losses. But I just want to understand your thinking on how long it will take before the CapEx and the business start delivering the return ratios this industry should typically earn, given how sticky and high-quality the business is.
Yes. You're correct that we're in the middle of the CapEx cycle. Within our industry, the development center OpEx should also be viewed as a form of CapEx, since it takes 2 to 3 years before revenue starts coming from it. So right now, we are — last year we launched the new initiatives, which we began in Germany; Manchester just came on stream this year, and the U.S., which came on stream last year. So 3 centers, costing almost INR 70 crores, INR 80 crores per year in OpEx, are also CapEx-like in nature, and they will begin generating revenue progressively, but after 3 years in terms of breakeven.
Sir, at the OpEx level, what are the losses right now in these new initiatives and development centers?
Until then, those centers won’t produce revenue. They’ll be solely a cost center. So...
What exactly is the scale of the losses we're absorbing here — I mean, how big are they?
It comes to approximately INR 80 crores to INR 85 crores a year when you combine everything.
I'd put those investments at around INR 80 crores to INR 85 crores, since they aren't losses. We're making products and providing samples, so development work is underway. But the figure comes to — as Jagdish said — INR 80 crores.
So when you take the roughly INR 350 crores of CapEx plus, say, another INR 200 crores in operating losses — which we're treating as OpEx — we're looking at something like INR 500 crores to INR 600 crores of investment. And I'm assuming that on that INR 500 crores to INR 600 crores, our internal hurdle rates mean we'd want at minimum an 18% to 20% return on equity, on top of whatever the business has historically earned. So is that the way we should expect things to play out over the next 1 to 2 years?
That's our expectation, though it won't happen within 1 to 2 years. It's going to take more time than that. The markets we're discussing are 20x larger than the original Indian market we started with. So building the capability and the market size will take time. Still, the growth runway is very, very large. The markets we're talking about are 20 to 25x bigger than the Indian market.
Yet could this fail to unfold the way we've mapped it out? In other words, is the momentum we're witnessing—and the reaction we're getting—tracking where it should be? Are we where we planned to be, or running a bit late? Had we foreseen just how tough this would prove? Since clearly, in these legacy markets, winning over such customers is no simple matter either, correct?
Regarding these markets, we remain on schedule. In the U.S., we have already observed business exceeding 1 million contracted. So for these markets, we are where we need to be. We had not anticipated or planned any large CapEx in India. Unfortunately, because of the fire incident, we were required to undertake a significant reassessment and reinvestment in the Indian CapEx. That is the area in which we have experienced a temporary setback regarding when we can rebuild our factories this year and be ready to go again.
Is there any guidance you can provide for the year ahead?
I'd call this a pretty tough one to answer, honestly. We're looking at an unclear road ahead regarding where raw materials will stand and how pricing and inflation will play out because of the Iran–U.S.A standoff. And since we really aren't in a spot to hand you a full-year picture, I'd say for quarter 1 we've locked things down across our businesses — both the price increases and the supply contracts plus inventories. So a normal quarter 1 is what we're on track for. Same with quarter 2, I believe: we have initiatives ready that let us hold our margins and keep growing. After that, we'll continue taking steps so that we stay aligned with inflation and the market environment in every region where we operate. Beyond the first half, I think it's very hard to offer a certain view of where the market is going or what the net effect on inflation and the growth rate might be that we can assume. Right now, we don't see any cause for concern for the first half of the year. We're adequately covered. We see enough growth — more than enough growth — and good win rates when it comes to our product range development for last year.
All right, then. And sir, if any problems come up with RM pricing, I'm assuming our contracts would let us pass that along, correct?
Yes, we can pass along the increases in raw material prices. We're also getting ready for the raw material situation to deteriorate. As Jagdish said earlier, we have exited INR 35 crores, which works out to roughly INR 50 crores of business — business that carried low or negative margins under the new conditions. We have exited that business through a onetime sale to those clients. We'll keep watching and monitoring sales closely. Given the shortages expected in raw materials and the inflation in prices at present, we will watch closely how we use the raw material. Our overall strategy would be to direct the raw material — which I believe will not be available globally in its full entirety — toward the right long-term clients and clients with the right margin profile.
And looking ahead, should we expect margins to now come down a bit, to at least the teens — the low teens at minimum?
Yes.
And we expect that to happen this year — I mean, it's the tariff?
Yeah, I believe we’ll get there fast.
Our next question comes from Henil Bagadia at Equicorp.
With things as they stand right now, sir, what sort of effect are we seeing when it comes to the increases in your RM prices, especially since even the secret — so orange, lemon, and grape fruit — has been affected, and the crude derivative RM price has been affected too? And since you mentioned that you've already put increases through, is there — will there be a repeat of what happened before, when we had actually ended up locked into high-cost inventories and it then took us 1, 2 quarters to return to normalized EBITDA even after the situation had actually cooled down? So do you see anything along those lines happening at the moment?
Not really. The way I see it, inventory prices are rising. Putting an exact figure on it is very difficult, but upwards of 12%, 13% plus. Pretty much across the board, operations are seeing inflation in power and fuel, and we expect these operating parameters to inflate further. We are prudently making sure we have raw material at the right prices, and we have contracts in place and material coming in. And then we look to sell to our clients based on the stock in hand rather than any future raw material pricing or contracts. So we are more or less looking at 2 to 3 months of inventory, raw materials in hand, and communicating and committing to the clients the prices based on those raw materials. And we will continue this process every 2, 3 months to ensure we are not caught with excess inventory and/or with a mismatch between the selling prices and raw materials.
Alright. Sir, turning to the international markets, what we've observed is that revenue in the U.S. has actually edged up by roughly $1 million. So, in terms of timelines, when do you expect the U.S. to become profitable — first at the EBITDA level and then at the PAT level? And also, in the case of the U.S. markets, if it's going to take us at least 1.5 years to reach breakeven — that's according to my own estimate at the EBITDA level — and considerably more growth and even longer timelines for PAT. And even if we treat the U.S. market as homogeneous and a large opportunity, it is far more competitive even when compared with the Europe one. So how do you view our growth strategy, apart from the inorganic one, where it can genuinely scale growth in a very significant way given the current headwinds?
I mean, looking at the growth strategy, on the inorganic side we typically pay 12 to 13x EBITDA, and that works out to a breakeven period of about 5 to 6 years. With our organic strategy — what we're putting money into in the U.S. — breakeven will come in roughly 4 years or sooner. So we're in a strong position to deliver that growth. The signs we're seeing are very encouraging. I mean, disruptions like the ones we're seeing right now are actually good opportunities rather than disturbances, because in this kind of environment clients will explore alternatives.
All right. So when we first came into the U.S. market, we did have certain plans for leveraging some of our patents. So in that context as well, you could refer to the timelines for when the patents we've filed are set to expire. And also, if we look at the patents belonging to other F&F companies that are due to expire, what timelines do you see there? So first of all, do we have an interest in moving into those products, technologies, and blends? And second, if we do have that interest, what's the timeline from actually reengineering the product through to batch orders and then to actual large commercial orders?
We're not like pharma, where patents are a way to get into an existing market or grab market share. For us, patents line up more with new innovations, and they help us build products that are differentiated for our clients. So patents aren't products we sell directly. We take these patented products and use them in our design.
All right, turning to Europe — since that plant is now commercialized, what sort of timeline do you foresee before we can actually get to an optimal level? And given that we've added roughly the same capacity as what we're currently running, which European geographies — which countries — do you intend to target, both as a new entry and then in terms of deepening penetration?
So, as you're aware, we've launched our center in Germany. By now the site is completely set up — all the CapEx systems, the IT systems, staffing, and raw materials for every laboratory. The labs have been running at full capacity for the past couple of months. We now also have an additional facility in Alma in the Netherlands. So we're targeting Northern Europe, Eastern Europe, Poland, Germany, and the Benelux region for ongoing growth. Last year we finished with roughly 10 million in sales at the Netherlands production site for sale. And then we carried on — we relocated this into the new facility. So from day 1, it's already been fully operational, with that 10 million in yearly sales.
Alright. Sir, and finally, we have observed the antitrust — I mean, the rulings that have been issued against the F&F companies. And the FMCG companies have likewise expressed that they want — they are prepared to actually put money into joint development alongside other fragrance companies. So do you see, in some way, a strategic tie-up with certain FMCG companies, whether it involves co-owners of IP and you receive a framework order, or is this simply going to require a lot of time?
No. Regarding the antitrust bid, there’s nothing more we’re doing and no additional work underway. That said, we do observe it influencing some buyers, leading them to consider other suppliers. As for your second question — well, there isn’t really a question there.
So there isn't any kind of co-ownership arrangement with the FMCG companies you're working with at the moment?
No, what exactly are you referring to by co-ownership, which...
With co-ownership, the big F&F players are the ones holding the patent or the blend, as a rule, and they tend not to reveal formulation secrets — that's exactly what has caused this whole situation to arise. So these companies are seeking access to the IP blends.
I'd say we do some of that over in Europe with tolling manufacturing, though it isn't really our core business.
<<operator_script>> Our following question comes from Anurag Patil, who is on the line from Quest Investment Managers.
Sir, how much of our raw material would you say is tied to crude?
Roughly, I'd put it this way: 40% ties straight to crude, while another 30% connects to crude indirectly in some way. Freight, logistics and so on will have an impact across the board.
All right. And sir, if we assume things stay as they are right now on the raw material side, then for the first half, are we able to hold that 40% gross margin, or is there more risk to the downside?
For the first half, I think we can hold this margin. Right now, we've got the raw material covered, and barring anything else coming up, we should be able to keep the business at a gross margin of 40% plus.
All right. And sir, regarding the flavor side, your margins have gotten better from one quarter to the next quite nicely. So is there any particular reason for that?
No, I'd say the growth in flavor has really taken hold. So margins are correspondingly stronger. On top of that, we're getting operating leverage thanks to how quickly volumes are rising.
The next question comes from Abhijit Akella at Kotak Institutional Equities.
To start with, on the revenue growth front, when I make an adjustment for that INR 35 crore one-off liquidation—which as I understand it related to the India geography—it looks as though India revenues would have come in slightly lower versus the prior year. So there is a bit of sluggishness there across India, and perhaps somewhat across Europe as well once we adjust for how the rupee depreciation affected things. So I'd just like your thoughts on the demand environment and the revenue growth profile. In other words, how are we viewing the market? And do we anticipate some acceleration in that growth as we go into the coming year?
Let me tackle this in two parts. On the European side, as we mentioned last year and over the past few quarters, growth has been muted, mainly because our execution capability had us running at full capacity. So we tried to take on only meaningful business. We now have new capacity in Europe that will let us grow quickly and get back to the double-digit plus growth rates we're aiming for over the next few years, since we've doubled our capacity, and I think we can grow that business aggressively. On the India side, and the Asia side as well, there is demand. There have been some shipment delays to the Middle East and some uncertainty that arose in the month of March, which caused volumes in the India business to drop. But these businesses have recovered, and our supplies have continued since then. So there's no reduction in demand per se as we speak. We do, however, remain cautious. I think the full impact of inflation in India hasn't been felt yet, since oil, petrol, and diesel prices haven't gone up. But I believe that as we see the writing on the wall, we see inflation hitting us.
We're ready for that, and in a high-inflation setting, our strategy of holding substantially more inventory consistently works out well — we always witness solid demand when inflation is elevated. So even if overall business growth turns sluggish within the competitive space, our growth has a tendency to outpace the market whenever inflation runs high.
Okay, sorry — just one clarification about that remark on Middle East shipments. If you look at ROW sales this quarter, they're up roughly 34% year-on-year. So I'm just trying to square that with what was said about some shipments being disrupted in March.
Right, so the Middle East has seen robust growth. That expansion is still showing up for us.
Right, so is the Middle East its own thing, apart from the India geography? Or do exports from India into that region also exist, and are those captured within the India revenues?
No, the Middle East is its own thing. But what I mean is, you do have folks purchasing in India as well, and their final product's export to the Middle East is sort of what they rely on.
Alright, one more thing from me — it's about how foreign exchange affects us. With the rupee having weakened so sharply, how should we think about the effect on our business, both on the revenue side and when it comes to employee costs and other expenses, which we've built up quite a bit in Europe and the U.S.? And could you also spell out how much FX added to revenue growth in the fourth quarter and in FY '26?
Jagdish, would you like to handle that question?
So, Abhijit, when we look at either the quarter or the full year, that's around 3%. The revenue attributable to the FX gain is 3% to 3.5%.
So that's 3% and 3.5%, covering both the quarter and the full year?
Yeah, pretty much along the same lines.
Okay. And taking into account how much we've put into staff and all sorts of things across Europe and the U.S., do we still come out ahead from the rupee weakening? Or should we be bracing for some margin pressure?
We are seeing a bit of margin pressure, since there is a dollar-denominated loan on our books, and that is going to create a translation effect. Apart from that, if you look just at revenue transactions, we are roughly neutral.
Our following question comes from Debanjana Chatterjee, who is on the line from Spark Capital.
Looking at the financials, I can see that if we set aside the current scenario, even across the last 3 quarters, your profitability was quite a bit lower despite revenue going up. So now that this added scenario has come in — and if this scenario hadn't been there — could we have expected some inability to grow this year?
Yes. Debanjana, your voice is cutting out, but I could — you're referring to the growth figure, is that right?
Yes. The way I'd frame it, Jagdish, is this: suppose those disturbances hadn't existed and inflation hadn't been a factor — where would we land by year-end? Take the guidance we've provided, and even looking at Q4 of this year, we're sitting at 13-something percent EBITDA from the operating business — the sustainable operating business. In a normal environment, we'd be above 13.5%, 14% EBITDA. We think we've taken sufficient steps to stay near that figure at least through the first half of this year. And we'll wait and watch, then take corrective action as needed, to make sure we don't drop under the 12%, 13% EBITDA level, which is what we intend to hold as a minimum.
For fiscal year '26, the EBITDA margin came in at 10.2%.
Right. I mean Q4 of this year — those one-off sales. Strip those out, and EBITDA comes to 13, and that's the level we're expecting from here on.
So you're also expecting a 13% EBITDA margin for the year ahead, is that right?
I have a lot of confidence for the first half of the year. After that, we'll need to see whether any significant disruptive shifts occur. We'll adjust our strategy and tactics accordingly. Still, for that first half of the year, I'm quite confident we'll hit these numbers.
To reiterate what I mentioned, EBITDA.
So that 13% leaves out other income and those other items, or are you referring to just the core EBITDA figure?
On a like-to-like basis, Debanjana — that's what we mean when we discuss adjusted EBITDA — the visibility suggests we ought to be able to hold that level through the first half. The first quarter, for sure, is more creative, but as for the second quarter, wait and watch. Still, we're pushing every action needed to make sure that at least across the first half, we can keep adjusted EBITDA where it stands now.
Alright. And moving forward, could you simply enumerate the main growth drivers that are going to propel the business over the upcoming quarters — so if you could just give us a consolidated sort of…
Let me break the business down into 3 parts. First, we have what are essentially the mature operations, which means the India fragrance business plus the Flavors business. Both of these have existed for over 20 years. We engage with clients on a regular basis. They are steady state, with continuous engagement and continuous growth. No major CapEx is required. The factories are already there, and so are the laboratories. So this accounts for roughly INR 1,300 crores to INR 1,400 crores of our business. Next comes the Aroma Global Ingredient business, which gets affected by inflation and by the global outlook for the business. Southeast Asia and the Middle East are what I would describe as Phase 2. We've been present in these markets for a good period of time. We keep growing. In Southeast Asia, we built our factory last year. We have the full centers in Jakarta and Singapore. So that business is now in a rapid growth phase, with engagement there and breakeven achieved. The Middle East has also been growing rapidly over the last few years. As for the European acquisitions, we had a slowdown because of capacity constraints over the last couple of years. We now have the new factory and a new development center in Germany.
Regarding Europe, we're aiming to get that business back to rapid expansion — double-digit growth. That's what I'd call the mature, established operation. Beyond that, we've got a center we've only just begun setting up in Manchester to serve U.K. and global accounts, and another one launched in the U.S. last year. Those 2 are what I'd describe as seeds, and revenue will need 3 to 4 years to ramp up in those geographies. Still, those geographies are pretty big markets. As I mentioned, they're 20 and 10x larger than India's market. So these represent our growth revenue, or growth areas, for, say, a 10-year horizon. India and Asia will deliver the growth — the continuing growth — that we have. And the Middle East, Southeast Asia and Europe will give us rapid growth in the interim 3 to 4 years.
So what you're telling me is that in the Middle East and APAC, we get revenue visibility for 3 to 4 years. India already has that. Altogether, that's roughly a 10-year horizon, correct?
Right, this covers a 10-year horizon. We have long-term future investments in the U.K. and the U.S.A., midterm ones in Germany and Southeast Asia — Europe and Southeast Asia — and short-term growth that keeps going in India and the Middle East in flavors and ingredients.
All right. So what sort of borrowing and CapEx do you have planned for this current fiscal year, FY '27?
At the end of March, gross debt stood at INR 851 crores. And in the near term, we do anticipate a modest increase, since we're currently securing supply, and as part of that effort, we may need to build up some inventory. Yet looking over the long term, we certainly expect to bring our debt down by 10% with each year that goes by. That is the target we have set.
A 10% cut.
During the partial year, though, in the interim period, over the next 3 to 6 months, we may find that it rises above the level we're at as of today.
On the CapEx side, construction has begun at our Almere factory. The Vanavate facility will be up in the next couple of months, and Vashivali follows after that. So during this year's first 6 months, we still have CapEx work to finish. There's going to be a lag before the insurance money arrives relative to the CapEx. As a result, those debt levels will stay elevated for a while. After that, they ought to begin declining.
Could you provide us with figures for both borrowings and CapEx for FY '27?
Could you repeat that?
Could you provide figures for both borrowings and CapEx for FY '27?
CapEx should come to roughly INR 140 crores. That covers all of the CapEx, and the bulk of it lands in the first 2 quarters, weighted toward the front.
Borrowings?
We expect borrowing to stay at roughly INR 800 crores.
All right, so what would the cash conversion cycle come in at? Are we going to see it rise to 150 days, or does it stay below that 100-day mark? What's your view on that?
Right now, the cash conversion cycle sits at roughly 140 days. We expect it to stay at that level until inflation reaches something like a steady state, since when inflation runs high, we hold larger inventory levels.
Our next question comes from Jatin Chawla, who is calling in from RTL Investments.
Let me start with my first question. When I look at your employee cost and depreciation, both of them kept rising again in this quarter. So year over year, there's a substantial jump, almost entirely on employee cost, going from INR 75 crores to INR 100 crores, and depreciation moving from INR 25 crores to nearly INR 40 crores. So my understanding was that as of the end of last quarter, we were saying our PVC investments are mostly finished and these figures would begin to level off. Why do they keep climbing?
If you look at employee cost from one quarter to the next, it moved from INR 93 crores to INR 100. And during the March quarter, we had a one-off impact related to MTM that came into our trust. That one-off impact in the March quarter was roughly INR 6 crores. At this point, our typical quarterly employee cost falls in the INR 94 crores to INR 95 crores range, which is roughly consistent with what we saw in the December quarter.
What about depreciation?
On depreciation, there is one reclassification item that has moved out of other expenses. If you look at other expenses, they are lower than what we had in December. So there is a one-off impact of around INR 5 crores to INR 6 crores that has shifted from other expenses into depreciation. So that is one reclassification we have.
Understood, understood. I believe during the previous conference call, you said a detailed plan would be shared covering how your adjusted EBITDA margins could rise from 13% to 17% across the coming 2 to 3 years. That plan hasn't appeared so far. Is there any specific cause behind the hold-up? And when might we expect to see it?
During the previous investor call, I believe we discussed the outlook covering 3 years. We said that reported EBITDA, currently at 10%, would reach 14% by the close of FY '29. We mentioned 400 basis points. However, right now circumstances shift nearly every other day, so it's a rather dynamic situation. We'll return to that topic. Still, as things stand, priorities differ and the situation is different.
Let me restate this: I believe the situation has shifted entirely since that 7% in March. So our attention is very much on making sure we deliver quarter on quarter over the coming few quarters, rather than on the longer-term strategy. That longer-term strategy remains in place, and nothing about it has changed. So we stay focused on making sure we don't fall behind on costing, pricing, and communication with the clients. I have to say we're pleased that even the large global accounts have responded and confirmed they're committed to supplying us, with price increases to us. We're well positioned for the first half of the year. And we'll keep monitoring raw material and communicating with our clients weekly, daily, to make sure there are no slippages in orders and that we can hold our margins in this scenario.
Just a quick follow-up on that point. I believe during the previous quarter you also noted that a portion of your cheaper raw materials hadn't been able to show up in the numbers since revenue came in somewhat lower, and you expected that to happen at the latest by 1Q or for the most part by 4Q. Right, we can see in the 4Q results that it didn't occur. Yet in 1Q, we were anticipating gross margins would really begin to improve thanks to the lower cost RM we had. So does that mean we should now expect no gross margin improvement at all, and that at best they would be roughly at the same 42.5% level we saw in 3Q?
I think the gross margin improvement has taken place, and that's the reason we're seeing this gain. During March — particularly over the final few weeks of the month — we needed to purchase certain solvents and some cheaper materials at market prices, and those prices jumped suddenly. As a result, we saw a slight dip in margin too. Even so, at 42.3% net of one-off items, we held that level in quarter 4. Margin will remain under pressure, we expect, yet we should be able to sustain 42% and roughly that level through the first half of the year. If you look at it on an inflation basis, margin will actually be better, because both the top line and the bottom — that is, cost and revenue — will rise. Expressed as a percentage, this will put pressure on the gross margin percentage. In absolute gross margin and profitability terms, though, we're highly confident about holding and about pushing pricing through to our clients as needed. Our aim for this year is making sure we retain the right kind of business, and we've already taken major steps to remove low-margin business from the portfolio. So a portfolio rejig is coming.
Our focus is on building a business with solid gross margins and strong cash conversion. So any operations with extended lead times, lengthy payment cycles, or thin margins — those are the ones we intend to cut out. What we want is to direct the raw material we have toward the right types of clients.
And since you've walked away from, as you put it, roughly INR 50 crores of business, is that going to hurt the growth we're expecting in FY '27?
My answer would be no. Overall, I believe demand is strong. What we're aiming for is to make sure the business's margin portfolio, or margin profile, stays where it should be. I don't see this INR 50 crores posing a growth problem for us. I think we'll keep growing. We already have very strong signals across the 45 days of this quarter. And there is — I mean, demand is strong, and we're getting ready for the worst-case scenario on raw material, so that we have no product in our portfolio with a negative margin at all. That was one of the reasons behind the big jump, or big dip, in gross margins during inflationary periods. So we've made a structural change, but I don't believe this will impact our overall growth, because our European growth will now pick up at a quicker pace.
Our following question comes from Rohit Nagraj, who is calling in from 360 ONE Capital.
To start with, since mid- and small-sized enterprises make up most of our industry, and you offered a confidence outlook covering the next 6 months — that we're secured on both raw material supply and the orders front — have we observed any shutdowns, or perhaps orders moving over from those mid- or small-sized players to us, given that we have the capability to serve those customers consistently?
I don’t have a precise figure or a precise dollar amount to give you, to be honest. What I think has clearly been the pattern historically is that whenever raw material costs spike very suddenly, because we carry more inventory, our increases in selling price tend to be measured rather than abrupt. That tends to help us pick up share. And in the first few weeks of this quarter as well, we believe we’ve picked up share, particularly in India. So yes — the smaller your operation, the smaller the inventory cushion you have, and the more vulnerable you are to this kind of volatile environment.
Absolutely. And then, secondly, touching a bit again on the guidance side. So for FY '27, we posted absolute EBITDA of nearly INR 300 crores on a consolidated basis. This year, that figure has dropped by roughly 18% year over year. Do we expect that in FY '27 we will be able to recover the FY '25 figures, or is it more likely to slide to perhaps mid-FY '28 or FY '28?
I'm genuinely confident that we'll reach INR 300 crore plus EBITDA this year — really so for the first half, where visibility is greater — but I'm confident we can exceed 25%, or at minimum land at the 25% level, for this year.
Our following question comes from Tanish Jhaveri at Boring AMS, who is on the line.
My question was really more about demand. How do you expect demand to shape up over the next year and 2? And given — as you mentioned, higher inflation works in our favor — do you think demand will take a hit because inflation is higher?
Yeah, I'd say demand overall is going to be muted. I don't expect the kind of growth rate we see in normal years. Demand is going to be muted. There's likely to be a transition phase, probably in the first half of the year, while demand works through the new post-inflation scenario. Industry-level growth rates will come down somewhat. As for the benefit from market share gains, we'll see normal growth.
Can you put a number on what that normal growth would be, and is there any way for us to have confidence in it? For example, are you spotting any green shoots?
I mean, we've witnessed this at different points—whenever there's been a major disruption, whether during the pandemic or at other moments. When a big disruption occurs, we've observed quicker growth.
Our following question comes from Bharat Sheth, who is calling in from Quest Investment Managers.
To understand the portfolio optimization a bit better — this INR 35 crores, is that the end, or is there still room for further optimization of the portfolio in the next years? To what extent do we expect that?
This is an exercise we keep working through—talking with clients about pricing, where we think costs will land, what the new price should be, and making corrections along the way. What we've done is this: some clients are structurally low margin, have been low margin, and there are long lead times, credit crunch, the whole cash conversion cycle. And when we look at whether this business is sustainable against inflation, we've made the call to exit those businesses. That has also been a strong case with some of our clients, and we're happy to commit that we have gotten price increases with many of the clients. So we have a good situation at the moment. But we will keep monitoring. We've put in place a monthly monitoring system so that every time there is a production order, the costing and the impact of inflation is then communicated to the account manager and, directly or indirectly, to the customer. So we don't fall behind the curve anytime throughout the year. If inflation continues, if we have a shortage or supply disruption on any material, we will pass it on to the clients as soon as we have information.
And at the close of the previous quarter, we brought in extra inventory—so we now hold an added 30 to 40 days of stock on hand—in order to offset the longer lag before inflation's impact is passed through.
And is that a fair way to put it as of today — meaning there isn't any additional optimization we're anticipating, right?
I mean, we don't anticipate any meaningful quantum here. We'll keep working with clients and keep making sure transactions and dealings are fair. We can't end up in a situation where margins get compressed further. So the cost will be passed along to the clients. And yes, I think we'll be able to secure those increases.
To get a sense of when this new factory we expect in the coming months will be commissioned — when does it really begin to reach the production level that we need to make it a positive EBITDA level? And second, again on the same line approval, how long will the approval from the client take? If you can give some color, so maybe 1 year time or 2-year time?
Hopefully, the factory will be operational by the close of this quarter. Transitioning from one factory to the other will require 6 months. So it's not the case that on day 1, every factory — every operation will be...
Yeah, yeah.
So roughly by the first quarter of the next financial year, it should be running at full capacity, with every product moved over and another plant essentially relocated and shut down. So during this year, we'll be going through a transition involving 2 factories. In the following year, one of the Mulund facilities will be shut.
All right, so where does that stand at the moment? When are we expecting to get it started?
The factory will be the first to begin. The Vashivali factory is going to take some time. We have essentially restarted construction on the building. So at some point this year, probably in the third quarter, that facility will be ready. We may not require it given the current environment, since we don't see that much growth, and we'll bring it on stream slowly. Again, that factory ought to be operational by next year.
All right. How are we viewing this now with the European business, which you mentioned will start up again? And is it fair to understand that this is a somewhat higher-margin business compared with the other one? So how do we see it — I mean, we think of — again, that could help us in some way with the improvement in EBITDA?
Okay, I’d break this into two parts. First, there’s the euro-related cost side, since currency exchange hits us harder as well. So when we generate more sales in Europe, whether in euro or USD, that helps us defend our margins and our overall operating cost more effectively. At this point we have twin growth engines: the Germany creation center is fully ready, with salespeople coming on board and taking up Eastern Europe, while Germany becomes a new market for growth, and then there’s the factory in Almere, Netherlands. So those 2 initiatives are now, in a sense, driving the European business back into a high-growth phase.
You also mentioned that we've received an order worth roughly 10 million from the U.S. So how long will implementation take? And over what period do we expect that to convert into revenue?
No, that's 1 million orders. For the year, it's already converting. So in the U.S. we already have some 200,000-odd business that we hold. So it isn't something that's sort of waiting to convert. Those orders are already in hand. As we move through the year, we expect additional orders.
Alright. And the final question regarding flavor — you had expected an order from a big MNC, similar to the one we received on the franchise side. So is there anything you can share on that?
Nothing more to add on that front. On the flavor side, our position is solid. We keep seeing robust growth. There isn’t any particular one-time order, though our plant has been audited and it has been approved. So the signals and the direction are moving the right way. From flavors too, I’d say we hold some quite appealing long-term agreements with our vendors. Now, whether every one of those contracts will be honored as they ought to be, we can’t be certain. Up to now, they have been honored, and there’s no reason for worry. Should that hold over the coming 2, 3 months, we’ll know that — meaning our cost structure relative to the competition — we will be very well positioned.
Ladies and gentlemen, we'll treat that as the final question and bring the question-and-answer session to a close. At this point, I'll turn the conference back over to management for their closing remarks.
Thanks. So, thanks. I hope we've managed to address your questions. If you require any additional clarification, or would like further information about the company, please don't hesitate to reach out to our team or CDR India. Thanks again for making the time to be with us on this call.
Thanks. That brings this conference call to a close on behalf of S H Kelkar and Company Limited. We appreciate your participation. You can go ahead and disconnect your lines now.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete S H Kelkar and Company Limited transcript - plus 132,000+ transcripts from 7,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.
Get an API key View API docs →For developers and AI pipelines
Programmatic access to S H Kelkar and Company Limited earnings transcripts and 132,000+ others is available through the
EarningsAPI REST API and the hosted MCP server.
Quarterly plans from $162 - full transcripts, speaker segments, full-text search,
and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.